Gosset Ownership
Private
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Axent Biosciences General Information
Axent Biosciences develops next-generation stem cell therapies using proprietary manufacturing and implantation platforms. The company has received a $4M CIRM grant to develop scalable, high-quality cell therapy for Parkinson’s Disease. As of now, the company remains pre-clinical with no reported clinical trial results.[5][6]
Contact Information
Primary Industry
Biotech
Corporate Office
Berkeley, CA
USA
USA
Drug Pipeline
No pipeline data available
Key Partnerships
Not explicitly listed; academic partnership with UC Berkeley as spinout [2], funding from CIRM [5]
Axent Biosciences Funding
No funding data available
To view Axent Biosciences's complete valuation and funding history, request access »